StockData
Achieve Life Sciences, Inc. logo

Achieve Life Sciences, Inc. (ACHV) stock

ACHVNasdaqIn Vitro & In Vivo Diagnostic SubstancesFiscal year ends December 31Also trades as QUIT
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 10, 2026Score 4/30
$6.72+0.34 (+5.33%)

Close on Nov 6, 2026Market cap $691.50MP/E –Yield –

Achieve Life Sciences price to book ratio

The price-to-book ratio is market cap divided by shareholders' equity.

Achieve Life Sciences's price to book ratio was 32.0× on Jul 31, 2026, against 8.8× a year earlier. Over the last 5 years it ranged from 1.5× to 250.9×, with a median of 4.8×.

Price to Book Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Jul 31, 202632.0×+24.2
2025Dec 31, 20257.8×+4.0
2024Dec 31, 20243.9×−17.7
2023Dec 29, 202321.6×−1.2
2022Dec 30, 202222.8×+20.7
2021Dec 31, 20212.1×+1.0
2020Dec 31, 20201.1×−9.4
2019Dec 31, 201910.6×+2.2
2018Dec 31, 20188.4×−279.7
2017Dec 29, 2017288.1×+287.1
2016Dec 30, 20161.0×−0.5
2015Dec 31, 20151.5×−0.5
2014Dec 31, 20142.0×−2.4
2013Dec 31, 20134.4×+0.1
2012Dec 31, 20124.3×−0.2
2011Dec 30, 20114.5×–

More Achieve Life Sciences figures

See a number that looks wrong?